Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
Details : Epioxa (riboflavin) is a small molecule drug candidate, which is being evaluated for the treatment of patients with progressive keratoconus.
Product Name : Epioxa
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
February 24, 2025
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Details : Epioxa (riboflavin) is a small molecule drug candidate, which is being evaluated for the treatment of patients with progressive keratoconus.
Product Name : Epioxa
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 23, 2024
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Glaukos Achieves Primary Endpoint in Phase 3 Epioxa™ Trial for Tolerability
Details : Epioxa (riboflavin) is a small molecule drug candidate, which is being evaluated for the treatment of patients with progressive keratoconus.
Product Name : Epioxa
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 16, 2024
Lead Product(s) : Riboflavin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable